Pfiz­er yanks blood pres­sure meds amidst on­go­ing, in­dus­try-wide ni­trosamine prob­lems

For four con­sec­u­tive months last year, Pfiz­er yanked its an­ti-smok­ing drug Chan­tix off of the shelves, and halt­ed dis­tri­b­u­tion, af­ter lots were found con­t­a­m­i­nat­ed with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.